Alzheimer's Assocation Research only
All of
  • Go to
  • Research Center
  • AAIC
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2007

To view an abstract, select an author from the vertical list on the left.

2007 Grant - Aubert

Novel Approaches to Generate Cholinergic Neurons From Progenitor Cells

Isabelle Aubert, Ph.D.
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada

2007 Investigator-Initiated Research Grant

Neurotransmitters are chemicals secreted by neurons for the purpose of sending signals to other neurons. Neurons in the brain that use the chemical acetylcholine as their neurotransmitter are called cholinergic neurons. These cells are known to be particularly susceptible to cell death during early stages of Alzheimer's disease. Cholinergic neurons in the brain participate in many learning and memory functions that are known to decline during progression of the disease. Some evidence suggests that replacing cholinergic neurons may improve the symptoms of Alzheimer's disease in affected persons.

Isabella Aubert, Ph.D., and colleagues have found that a naturally occurring chemical (polysialic acid), found on the surface of developing and regenerating neurons, limits the ability of those cells to produce acetycholine. In contrast, some growth factors increase the production of acetylcholine. (Growth factors are molecules that help direct the growth and development of cells.)

The researchers have developed a way to block the effects of polysialic acid, and they plan to study whether blocking polysialic acid and using growth factors improve the production of acetylcholine by cholinergic neurons. They will use these modified cells to replace missing cholinergic cells in an animal model that shows many of the same brain abnormalities as those found in people with Alzheimer's disease.

Dr. Aubert and colleagues will then examine whether these cholinergic neurons slow or halt the progression of behavioral and biochemical changes seen in untreated animals. These studies may lead to improved treatments for the brain degeneration seen in patients with Alzheimer's disease.

Alzheimer's Association International Conference | July 16-20, 2017, London, England

Abstract Submissions Now Open

The Scientific Program Committee is now accepting submissions for poster
presentations, oral presentations and featured research sessions.